Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Everything Else, Added, 2013 Q3, Page 6

CITADEL ADVISORS LLC historic quarter change: USA Everything Else, Added

In partnership units, exchange-traded notes and anything else (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 11,824 positions, added to 16,498, reduced 15,969 and sold out of 13,072.

  • Q3 2013: Stock HEMISPHERX BIOPHARMA INC CMN STOCK; Country of operation —; Class Cmn; Shares before 16,568.
  • Q3 2013: Stock GALENA BIOPHARMA INC; Country of operation —; Class Cmn; Shares before 10,485.
  • Q3 2013: Stock MANNING & NAPIER INC; Country of operation —; Class Cmn; Shares before 15,211.
  • Q3 2013: Stock VECTREN CORP CMN STOCK; Country of operation —; Class Cmn; Shares before 16,588.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2013HEMISPHERX BIOPHARMA INC CMN STOCK
CUSIP 42366C103
—Cmn16,568107,276+90,708$4$25+$212013-11-14
Q3 2013GALENA BIOPHARMA INC
CUSIP 363256108
—Cmn10,48519,256+8,771$23$44+$212013-11-14
Q3 2013MANNING & NAPIER INC
CUSIP 56382Q102
—Cmn15,21117,450+2,239$270$291+$212013-11-14
Q3 2013VECTREN CORP CMN STOCK
CUSIP 92240G101
—Cmn16,58817,443+855$561$582+$212013-11-14
Q3 2013ACHILLION PHARMACEUTICALS IN
CUSIP 00448Q201
—Cmn68,659179,156+110,497$561$541-$202013-11-14
Q3 2013AEROFLEX HOLDING CORP
CUSIP 007767106
—Cmn130,036143,034+12,998$1,026$1,007-$192013-11-14
Q3 2013BALLANTYNE STRONG INC
CUSIP 058516105
—Cmn27,84532,133+4,288$118$136+$182013-11-14
Q3 2013ENGLOBAL CORP CMN STOCK
CUSIP 293306106
—Cmn7,23622,548+15,312$7$22+$152013-11-14
Q3 2013MCCLATCHY COMPANY -CL A CMN STK
CUSIP 579489105
—Cmn2,4957,066+4,571$6$21+$152013-11-14
Q3 2013MEETME INC
CUSIP 585141104
—Cmn3,65410,259+6,605$6$19+$132013-11-14
Q3 2013ENZO BIOCHEM INC CMN STK
CUSIP 294100102
—Cmn10,14513,059+2,914$21$33+$122013-11-14
Q3 2013SILVER BULL RESOURCES INC
CUSIP 827458100
—Cmn12,81548,360+35,545$5$17+$122013-11-14
Q3 2013FREDS INC CMN STK
CUSIP 356108100
—Cmn22,73723,189+452$352$363+$112013-11-14
Q3 2013SOUTH JERSEY INDUSTRIES CMN STK
CUSIP 838518108
—Cmn7,2287,279+51$415$426+$112013-11-14
Q3 2013BROOKFIELD PROPERTY PARTNERS
CUSIP G16249107
—Cmn15,46315,665+202$314$304-$102013-11-14
Q3 2013GREAT PANTHER RESOURCES LTD COMMON STOCK
CUSIP 39115V101
—Cmn18,47627,586+9,110$14$24+$102013-11-14
Q3 2013CLEVELAND BIOLABS INC CMN STK
CUSIP 185860103
—Cmn6,24811,703+5,455$10$18+$82013-11-14
Q3 2013Lucas Energy Inc COMMON STOCK
CUSIP 549333201
—Cmn10,32316,961+6,638$13$21+$82013-11-14
Q3 2013DYNAVAX TECHNOLOGIES CORP COMMON STOCK
CUSIP 268158102
—Cmn17,90721,758+3,851$20$26+$62013-11-14
Q3 2013REXAHN PHARMACEUTICALS INC COMMON STOCK
CUSIP 761640101
—Cmn28,97242,132+13,160$13$19+$62013-11-14
Q3 2013PUTNAM PREMIER INCOME TRUST
CUSIP 746853100
United StatesCmn13,63014,783+1,153$73$78+$52013-11-14
Q3 2013CHINA GENGSHENG MINERALS INC
CUSIP 16942P101
—Cmn16,17834,699+18,521$2$6+$42013-11-14
Q3 2013GIGAMEDIA LIMITED COM STK
CUSIP Y2711Y104
—Cmn10,46214,094+3,632$10$14+$42013-11-14
Q3 2013MAJESCO ENTERTAINMENT CO CMN STK
CUSIP 560690208
—Cmn19,95527,767+7,812$11$15+$42013-11-14
Q3 2013Paramount Gold and Silver Corp
CUSIP 69924P102
—Cmn19,36520,316+951$23$26+$32013-11-14
Q3 2013APRICUS BIOSCIENCES INC
CUSIP 03832V109
—Cmn1,5143,421+1,907$4$7+$32013-11-14
Q3 2013BOTTOMLINE TECHNOLOGIES INC CMN STOCK
CUSIP 101388106
—Cmn602642+40$15$18+$32013-11-14
Q3 2013LOOKSMART LTD CMN STOCK
CUSIP 543442503
—Cmn10,25313,153+2,900$7$10+$32013-11-14
Q3 2013NEWLEAD HOLDINGS LTD
CUSIP G64626115
—Cmn23,04153,556+30,515$4$7+$32013-11-14
Q3 2013LIME ENERGY CO COMMON STOCK
CUSIP 53261U205
—Cmn21,25324,271+3,018$14$12-$22013-11-14
Q3 2013SWISHER HYGIENE INC
CUSIP 870808102
—Cmn14,21617,285+3,069$12$10-$22013-11-14
Q3 2013NXSTAGE MEDICAL INC CMN STK
CUSIP 67072V103
—Cmn63,51968,808+5,289$907$905-$22013-11-14
Q3 2013URANERZ ENERGY CORP COMMON STOCK
CUSIP 91688T104
—Cmn2,3014,315+2,014$3$4+$12013-11-14
Q3 2013NUPATHE INC
CUSIP 67059M100
—Cmn7,4079,044+1,637$23$22-$12013-11-14
Q3 2013STR HOLDINGS INC
CUSIP 78478V100
—Cmn67,45568,172+717$153$152-$12013-11-14
Q3 2013BIOTIME INC CMN STK
CUSIP 09066L105
—Cmn438580+142$2$2$02013-11-14
Q3 2013DARA BIOSCIENCES INC CMN STK
CUSIP 23703P205
—Cmn21,31426,133+4,819$13$13$02013-11-14
Q3 2013RESOURCE CAPITAL CORP COMMON STOCK
CUSIP 76120W302
—Cmn42,81144,462+1,651$264$264$02013-11-14